Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction
Journal of the American College of Cardiology · 2024
DOI: 10.1016/j.jacc.2024.02.035 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American College of Cardiology, 2024. Verfasst von Alberto Foà und 14 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiology Unit, Department of Medical and…. Hauptthemen laut MEDLINE: Valsartan, Hypotension, Heart Failure, Biphenyl Compounds. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Novartis Pharmaceuticals Corp.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
BACKGROUND: Hypotension is a potential adverse effect of sacubitril/valsartan, but there are limited data regarding the predictors and implications of treatment-related hypotension in heart failure (HF) with mildly reduced and preserved ejection fraction. OBJECTIVES: We investigated predictors of treatment-associated hypotension, clinical outcomes after hypotension, and the relationship between left ventricular ejection fraction (LVEF) and incidence of hypotension in the PARAGON-HF (Prospective Comparison of ARNI with ARB Global Outcomes in HF with Preserved Ejection Fraction) trial. METHODS: PARAGON-HF randomized patients with chronic HF (≥45%) to sacubitril/valsartan or valsartan. Following randomization, hypotension was defined as investigator-reported hypotension with a systolic blood pressure
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Cardiology Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologn…
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA; Division of Cardiology, Lausanne University Hospital, University of Lausanne, Lausanne, Vaud, Switzerland.
- Department of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
- Minneapolis VA Center for Care Delivery and Outcomes Research, University of Minnesota, Minneapolis, Minnesota, USA.
- Institut de Cardiologie de Montréal, Université de Montréal, Montreal, Quebec, Canada.
Förderung
- Novartis Pharmaceuticals Corp
Zitieren
APA
Foà, A., Vaduganathan, M., Claggett, B. L., Pabon, M. A., Lu, H., Pfeffer, M. A., Packer, M., Vardeny, O., Rouleau, J. L., Lefkowitz, M., Mentz, R. J., Jhund, P. S., Desai, A. S., McMurray, J. J. V., & Solomon, S. D. (2024). Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.02.035
Vancouver
Foà A, Vaduganathan M, Claggett BL, Pabon MA, Lu H, Pfeffer MA, et al. Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction. Journal of the American College of Cardiology. 2024. doi:10.1016/j.jacc.2024.02.035
BibTeX
@article{Fo2024,
author = {Foà, Alberto and Vaduganathan, Muthiah and Claggett, Brian L and Pabon, Maria A and Lu, Henri and Pfeffer, Marc A and Packer, Milton and Vardeny, Orly and Rouleau, Jean L and Lefkowitz, Martin and Mentz, Robert J and Jhund, Pardeep S and Desai, Akshay S and McMurray, John J V and Solomon, Scott D},
title = {Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction},
journal = {Journal of the American College of Cardiology},
year = {2024},
doi = {10.1016/j.jacc.2024.02.035}
}
EUVIMED